Since November 2018 clinicians can prescribe cannabis-centered solutions for medicinal use (CBPMs), but NHS prescriptions are tightly controlled and comparatively unusual. Common cases wherever CBPMs may very well be regarded as involve significant, therapy-resistant epilepsy plus some soreness/spasticity conditions — and in many cases then it us